DHR three-lens brief
Evidence-based stock research on DHR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 14.1pp over 30 days.
- Outperforming SPY by 14.1pp over 30 days.
- Analyst mean target $242.26 — 22% above current (23 analysts).
- Earnings scheduled 2026-07-21.
DHR closed at $198.16 (+1.11%) as of 2026-07-10. Market cap: $140.25B. P/E (trailing) 38.5. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 14.1pp over 30 days.; analyst mean target $242.26 — 22% above current (23 analysts).. Last quarter: Revenue $5.95B, net income $1.03B, free cash flow $4.57B. Watching for: 2026-07-21 earnings release (10 days out).
Why three lenses on DHR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine DHRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/DHR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath DHR brief"></iframe>